Biote (BTMD) Insider Ownership: 9.47 % (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTMD Biote Corp BTMD
59 GF Score
Price $1.66
GF Value $3.27
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Biote Insider Ownership?

Biote BTMD +1.22% 59 Insider Ownership is 9.47 % as of Sep. 01, 2026. GuruFocus rates BTMD with a GF Score™ of 59/100 and a GF Value™ of $3.27 (Possible Value Trap). The stock has 2 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biote's insider ownership is 9.47%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biote's Institutional Ownership is 47.58%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biote's Float Percentage Of Total Shares Outstanding is 70.93%.

Biote Insider Ownership Historical Data

* Premium members only.

The historical data trend for Biote's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biote Insider Ownership Chart

Biote Historical Data

The historical data trend for Biote can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 9.57 9.51 9.51 9.51 9.51 9.51 9.51 9.47 9.47 9.47
BTMD
59GF Score
Biote Corp BTMD
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biote Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 9.47 % mean?
Biote (BTMD) has a Insider Ownership of 9.47 % as of Sep. 01, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Biote and its competitors.
Is Biote's Insider Ownership too high?
Biote's current Insider Ownership is 9.47 %. Overall, Biote has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biote's Insider Ownership compare to DCGO and PIII?
Biote's Insider Ownership of 9.47 % can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Healthcare Providers & Services company?
A good Insider Ownership depends on the Healthcare Providers & Services industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Biote and its competitors. Biote's current Insider Ownership is 9.47 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biote stock overvalued right now?
Based on GuruFocus' analysis, Biote (BTMD) is currently considered Possible Value Trap. The stock's GF Value™ is $3.27, compared to a current price of $1.66 — trading 49.2% below its estimated fair value. The current Insider Ownership is 9.47 %. Biote's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Biote (BTMD), the current Insider Ownership is 9.47 % as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biote (BTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Biote stock appears to be undervalued. The current stock price of $1.66 is trading 49.2% below its estimated GF Value™ of $3.27. GuruFocus considers Biote to be Possible Value Trap.

Key valuation signals for BTMD:

  • Insider Ownership: 9.47 %
  • GF Value™: $3.27 vs. price of $1.66 (49.2% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biote Business Description

Address 1875 W. Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
59GF Score

Get the complete analysis for BTMD

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.66
Price
$3.27
GF Value